TY - JOUR T1 - Direct activation of STING in the tumor microenvironment with synthetic cyclic dinucleotide derivatives leads to potent and systemic tumor-specific immunity JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1186/2051-1426-2-S3-O10 VL - 2 IS - Suppl 3 SP - O10 AU - Leticia Corrales AU - Laura Hix Glickman AU - Sarah M McWhirter AU - David B Kanne AU - Kelsey E Sivick AU - Edward Lemmens AU - Justin J Leong AU - Ken Metchette AU - Thomas W Dubensky AU - Thomas Gajewski Y1 - 2014/12/01 UR - http://jitc.bmj.com/content/2/Suppl_3/O10.abstract ER -